173 S. C. Larsson et al., “Dietary potassium intake and risk of stroke: a dose-response meta-analysis of prospective studies.” Stroke: A Journal of Cerebral Circulation 42, no. 10 (October 2011): 2746–50.
174 Richard D. Moore et al., The Salt Solution (Avery, 2001).
175 F. Forouzandeh et al., “Metformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosis.” Journal of the American Heart Association 3, no. 6 (December 2014): e001202.
176 M. L. Wahlqvist et al., “Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson’s disease occurring with type 2 diabetes in a Taiwanese population cohort.” Parkinsonism and Related Disorders 18, no. 6 (July 2012): 753–58.
177 C. A. Bannister et al., “Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls.” Diabetes, Obesity and Metabolism 16, no. 11 (November 2014): 1165–73.
178 R. I. Misbin, “The phantom of lactic acidosis due to metformin in patients with diabetes.” Diabetes Care 27, no. 7 (July 2004): 1791–93.
179 S. R. Salpeter et al., “Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.” Cochrane Database of Systematic Reviews 1 (January 2010): CD002967.
180 M. S. HOOD et al., “Low-volume interval training improves muscle oxidative capacity in sedentary adults.” Medicine and Science in Sports and Exercise 43, no. 10 (October 2011): 1849–56.
181 J. P. Little et al., “A practical model of low-volume high-intensity interval training induces mitochondrial biogenesis in human skeletal muscle: potential mechanisms.” Journal of Physiology 588, no. 6 (March 2010): 1011–22.
182 S. Rovio et al., “Leisure-time physical activity at midlife and the risk of dementia and Alzheimer’s disease.” Lancet Neurology 4, no. 11 (November 2005): 705–11.
183 K. I. Erickson et al., “Aerobic fitness is associated with hippocampal volume in elderly humans.” Hippocampus 19, no. 10 (October 2009): 1030–39.
184 P. Sarup et al., “The long-term effects of a life-prolonging heat treatment on the Drosophila melanogastertranscriptome suggest that heat shock proteins extend lifespan.” Experimental Gerontology 50 (March 2014): 34–39.
185 M. Mattson et al., “Best in small doses.” New Scientist 199, no. 2668 (August 2008): 36–39.
186 J. R. Cameron, “Moderate dose rate ionizing radiation increases longevity.” British Journal of Radiology 78, no. 925 (January 2005): 11–13.
187 D. B. Panagiotakos et al., “Sociodemographic and lifestyle statistics of oldest old people (>80 years) living in Ikaria Island: the Ikaria study.” Cardiology Research and Practice 2011 (January 2011): 679187.
188 C. Chrysohoou et al., “Exposure to low environmental radiation and longevity. Insights from the Ikaria Study.” International Journal of Cardiology 169, no. 6 (November 2013): e97–98.
189 M. Ristow et al., “Antioxidants prevent health-promoting effects of physical exercise in humans.” Proceedings of the National Academy of Sciences of the United States of America 106, no. 21 (May 2009): 8665–70.
190 V. I. Sayin et al., “Antioxidants accelerate lung cancer progression in mice.” Science Translational Medicine 6, no. 221 (January 2014): 221ra15.
191 W. Yang et al., “A mitochondrial superoxide signal triggers increased longevity in Caenorhabditis elegans.” PLoS Biology 8, no. 12 (January 2010): e1000556.
192 M. H. Eskelinen et al., “Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study.” Journal of Alzheimer’s Disease 16, no. 1 (January 2009): 85–91.
193 G. W. Ross et al., “Association of coffee and caffeine intake with the risk of Parkinson disease.” JAMA 283, no. 20 (May 2000): 2674–79.
194 E. Salazar-Martinez et al., “Coffee consumption and risk for type 2 diabetes mellitus.” Annals of Internal Medicine 140, no. 1 (January 2004): 1–8.
195 M. S. Butt et al., “Coffee and its consumption: benefits and risks.” Critical Reviews in Food Science and Nutrition 51, no. 4 (April 2011): 363–73.
196 U. Boettler et al., “Coffee constituents as modulators of Nrf2 nuclear translocation and ARE (EpRE)-dependent gene expression.” Journal of Nutritional Biochemistry 22, no. 5 (May 2011): 426–40.
197 K. Trinh et al., “Induction of the phase II detoxification pathway suppresses neuron loss in Drosophilamodels of Parkinson’s disease.” Journal of Neuroscience: The Official Journal of the Society for Neuroscience 28, no. 2 (January 2008): 465–72.
198 M. J. Steinbaugh et al., “Activation of genes involved in xenobiotic metabolism is a shared signature of mouse models with extended lifespan.” American Journal of Physiology Endocrinology and Metabolism 303, no. 4 (August 2012): E488–95.
199 S. Ayyadevara et al., “Lifespan and stress resistance of Caenorhabditis elegans are increased by expression of glutathione transferases capable of metabolizing the lipid peroxidation product 4-hydroxynonenal.” Aging Cell 4, no. 5 (October 2005): 257–71.
200 A. A. Powolny et al., “The garlic constituent diallyl trisulfide increases the lifespan of C. elegansvia skn-1 activation.” Experimental Gerontology 46, no. 6 (June 2011): 441–52.
201 K. Canene-Adams et al., “Combinations of tomato and broccoli enhance antitumor activity in dunning r3327-h prostate adenocarcinomas.” Cancer Research 67, no. 2 (January 2007): 836–43.
202 L. Tang et al., “Intake of cruciferous vegetables modifies bladder cancer survival.” Cancer Epidemiology, Biomarkers and Prevention: A Publication of the American Association for Cancer Research 19, no. 7 (July 2010): 1806–11.
203 C. B. Ambrosone et al., “Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype.” Journal of Nutrition 134, no. 5 (May 2004): 1134–38.
204 P. Riso et al., “DNA damage and repair activity after broccoli intake in young healthy smokers.” Mutagenesis 25, no. 6 (November 2010): 595–602.
205 C. L. Saw et al., “Impact of Nrf2 on UVB-induced skin inflammation/photoprotection and photoprotective effect of sulforaphane.” Molecular Carcinogenesis 50, no. 6 (June 2011): 479–86.
206 L. Arab et al., “Green and black tea consumption and risk of stroke: a metaanalysis.” Stroke: A Journal of Cerebral Circulation 40, no. 5 (May 2009): 1786–92.
207 S. Bettuzzi et al., “Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.” Cancer Research 66, no. 2 (January 2006): 1234–40.
